A clinical trial to study the effect of ayurvedic drug formualtion Amrutadi Yog in patients with high blood presssure.

Phase 3

Recruiting

• Conditions: Essential (primary) hypertension,

• Registration Number: CTRI/2019/05/019423

Brief Summary

This study is randomised controlled trial to evaluate the efficasy of ayurvedic formulation amrutadi yog which contains Amruta *Tinospora cordifolia* Willd. Miers.exHK.F.and Th., Gokshur *Tribulus terrestris* Linn, Jatamansi *Nordostachys jatamansi* (D.Don) DC. Parsik Yavani, *Hysocymus niger* Linn. Amalaki *Phyllanthus emblica* Linn Haritaki *Terminalia chebula* Retz. Trial drug  dose 1 gm bid and control drug dose 20 mg once in day in the morning for 8 weeks for 110 patients in each group. study will be conducted in India. outcome of study will be asses on reduction of blood pressure and sign symptoms of hypertension.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-07
• Last Update Posted: 2022-11-21

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

Newly diagnosed patients of stage 1 essential hypertension with blood pressure systolic blood pressure is equal to and more than 140 mmHg and less than 160 mmHg and diastolic blood pressure is equal to and more than 90 mmHg and less than 100 mmHg.

Exclusion Criteria

• 1.Patients receiving anti-hypertensive drug.
• 2.Complicated hypertensive cases.
• Known case of Nephropathy, Left Ventricular Hypertrophy, heart block, Congestive Cardiac Failure, Coronary Artery Disease and retinopathy.
• Patients suffering from Diabetes Mellitus and severe other illness like hepatic or renal failure.
• 3.Secondary, Accelerated and Malignant Hypertension 4.Patients taking steroids, oral contraceptive pills, estrogen replacement therapy or NSAIDS group of drug 5.Pregnant women or planning pregnancy within six months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
reduction in blood pressure	8 weeks

Secondary Outcome Measures

Name	Time	Method
sign and symptoms of hypertension rlief	8 weeks

Trial Locations

Locations (2)

Dhanvantari Hospital Ashta; 🇮🇳 Sangli, MAHARASHTRA, India

MAM SSAMs Sane Guruji Arogya Kendra; 🇮🇳 Pune, MAHARASHTRA, India

Dhanvantari Hospital Ashta

🇮🇳Sangli, MAHARASHTRA, India

Varsha Khot

Principal investigator

09423565886

drvarshaskhot@gmail.com